These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1396734)

  • 41. Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.
    Muhvich KH; Park MK; Myers RA; Marzella L
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1526-30. PubMed ID: 2510593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reproducibility between two readout methods of a commercial broth microdilution assay for Pseudomonas aeruginosa isolates from patients with Cystic Fibrosis.
    Franssens BT; Fluit AC; Rentenaar RJ
    Infect Dis (Lond); 2019 Jan; 51(1):50-55. PubMed ID: 30654670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae.
    Barry AL; Schoenknecht FD; Norton R; O'Brien TF; Matsen JM; Thornsberry C; Thrupp LD; Markley E; Gavan TL
    J Infect Dis; 1976 Oct; 134(4):328-35. PubMed ID: 185302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.
    Baker CN; Stocker SA; Culver DH; Thornsberry C
    J Clin Microbiol; 1991 Mar; 29(3):533-8. PubMed ID: 2037671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas.
    Davis SD; Iannetta A
    Antimicrob Agents Chemother; 1972 Jun; 1(6):466-9. PubMed ID: 4218943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A demonstration of the susceptibility of clinical isolates obtained from cystic fibrosis patients to manuka honey.
    Jenkins R; Wootton M; Howe R; Cooper R
    Arch Microbiol; 2015 May; 197(4):597-601. PubMed ID: 25680398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
    Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A broth-disc technique for the assay of antibiotic synergism.
    Meyer M; Hofherr L
    Can J Microbiol; 1979 Nov; 25(11):1232-8. PubMed ID: 120215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Dibb WL; Asphaug Kjellevold V; Digranes A
    Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ansorg R; Müller KD; Wiora J
    Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formation of Pseudomonas aeruginosa inhibition zone during tobramycin disk diffusion is due to transition from planktonic to biofilm mode of growth.
    Høiby N; Henneberg KÅ; Wang H; Stavnsbjerg C; Bjarnsholt T; Ciofu O; Johansen UR; Sams T
    Int J Antimicrob Agents; 2019 May; 53(5):564-573. PubMed ID: 30615928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of a commercial microdilution minimal inhibitory concentration procedure for aminoglycoside susceptibility testing of Pseudomonas aeruginosa.
    Etowski DC; Beckwith DG
    Am J Clin Pathol; 1981 Jun; 75(6):830-3. PubMed ID: 6789668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of the inoculum concentration on the in vitro sensitivity of Pseudomonas aeruginosa].
    Zarakolu P; Cöplü N; Güvener E
    Mikrobiyol Bul; 1993 Jul; 27(3):211-5. PubMed ID: 8361409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C; Crevatin E
    Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.
    Smith AL; Fiel SB; Mayer-Hamblett N; Ramsey B; Burns JL
    Chest; 2003 May; 123(5):1495-502. PubMed ID: 12740266
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.